text Therapeutics (CNTX) - 2023 Q1 - Quarterly Report

Commission file number: 001-40654 For the quarterly period ended March 31, 2023 Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý No o Indicate by check mark whether the registrant is a shell company (as define ...